Thrombotic thrombocytopenic purpura as the initial presentation of COVID-19.
作者信息
Beaulieu Marie-Claude, Mettelus Danny Sebastien, Rioux-Massé Benjamin, Mahone Michèle
机构信息
Department of Medicine, Internal Medicine Divison, Centre Hospitalier de l'Université de Montréal, Montréal, QC, Canada.
Department of Medicine, Hematology Division, Centre hospitalier de I'Université de Montréal, Montréal, QC, Canada.
出版信息
J Thromb Haemost. 2021 Apr;19(4):1132-1134. doi: 10.1111/jth.15231.
Abstract
摘要
相似文献
1
Thrombotic thrombocytopenic purpura as the initial presentation of COVID-19.
J Thromb Haemost. 2021 Apr;19(4):1132-1134. doi: 10.1111/jth.15231.
2
Thrombotic thrombocytopenic purpura (TTP) response following COVID-19 infection: Implications for the ADAMTS-13-von Willebrand factor axis.
J Thromb Haemost. 2021 Apr;19(4):1130-1132. doi: 10.1111/jth.15230.
3
Imbalance of von Willebrand factor and ADAMTS13 axis is rather a biomarker of strong inflammation and endothelial damage than a cause of thrombotic process in critically ill COVID-19 patients.
J Thromb Haemost. 2021 Sep;19(9):2193-2198. doi: 10.1111/jth.15445. Epub 2021 Jul 27.
4
Immune Thrombotic Thrombocytopenic Purpura in a Patient with Suspected COVID-19: Hydroxychloroquine Culprit or Just Happenstance?
Turk J Haematol. 2021 Jun 1;38(2):155-157. doi: 10.4274/tjh.galenos.2021.2021.0057. Epub 2021 Feb 5.
5
von Willebrand Factor Multimer Formation Contributes to Immunothrombosis in Coronavirus Disease 2019.
Crit Care Med. 2021 May 1;49(5):e512-e520. doi: 10.1097/CCM.0000000000004918.
6
COVID-19 as a Potential Trigger for Immune Thrombotic Thrombocytopenic Purpura and Reason for an Unusual Treatment: A Case Report.
Hamostaseologie. 2023 Jun;43(3):215-218. doi: 10.1055/a-1497-1054. Epub 2021 Jul 29.
7
Acquired thrombotic thrombocytopenic purpura: A rare disease associated with BNT162b2 vaccine.
J Thromb Haemost. 2021 Sep;19(9):2314-2317. doi: 10.1111/jth.15420. Epub 2021 Jul 7.
8
Inherited thrombotic thrombocytopenic purpura mimicking immune thrombocytopenic purpura during pregnancy: a case report.
J Med Case Rep. 2018 Jan 22;12(1):15. doi: 10.1186/s13256-017-1545-3.
9
Recent advances in thrombotic thrombocytopenic purpura.
Hematology Am Soc Hematol Educ Program. 2004:407-23. doi: 10.1182/asheducation-2004.1.407.
10
[New marker in thrombotic thrombocytopenic purpura].
Ugeskr Laeger. 2008 Aug 11;170(33):2446-9.
引用本文的文献
1
Immune thrombotic thrombocytopenic purpura: pathogenesis and novel therapies: a narrative review.
Ann Blood. 2023 Sep 30;8. doi: 10.21037/aob-22-29. Epub 2023 Jan 6.
2
Coronavirus disease 2019-associated thrombotic microangiopathy treated with plasma exchange and antihypertensive therapy in a patient with HIV: A case report with literature review.
Medicine (Baltimore). 2023 Oct 13;102(41):e35469. doi: 10.1097/MD.0000000000035469.
3
The perfect storm: Thrombotic thrombocytopenic purpura (TTP) associated with COVID-19, a clinical case series and review.
EJHaem. 2022 Oct 26;3(4):1358-1364. doi: 10.1002/jha2.577. eCollection 2022 Nov.
4
Hereditary thrombotic thrombocytopenic purpura and COVID-19: Impacts of vaccination and infection in this rare disease.
Res Pract Thromb Haemost. 2022 Oct 21;6(7):e12814. doi: 10.1002/rth2.12814. eCollection 2022 Oct.
5
Coronavirus Disease 2019-Associated Thrombotic Microangiopathy: Literature Review.
Int J Mol Sci. 2022 Sep 25;23(19):11307. doi: 10.3390/ijms231911307.
6
Prognostic value of von Willebrand factor and ADAMTS13 in patients with COVID-19: A systematic review and meta-analysis.
Thromb Res. 2022 Oct;218:83-98. doi: 10.1016/j.thromres.2022.08.017. Epub 2022 Aug 18.
7
COVID-19-Associated Thrombotic Thrombocytopenic Purpura: A Case Report and Systematic Review.
Hematol Rep. 2022 Aug 2;14(3):253-260. doi: 10.3390/hematolrep14030035.
8
Relapse of immune thrombotic thrombocytopenic purpura (iTTP) possibly triggered by COVID-19 vaccination and/or concurrent COVID-19 infection.
BMJ Case Rep. 2022 Jul 28;15(7):e247524. doi: 10.1136/bcr-2021-247524.
9
Flavorubredoxin, a Candidate Trigger Related to Thrombotic Thrombocytopenic Purpura: Screening of the Complete Genome of a Serovar Typhimurium Isolate From an AIDS Case.
Front Cell Infect Microbiol. 2022 Jun 10;12:864087. doi: 10.3389/fcimb.2022.864087. eCollection 2022.
10
COVID-19 infection triggering Thrombotic Thrombocytopenic Purpura.
IDCases. 2021;26:e01256. doi: 10.1016/j.idcr.2021.e01256. Epub 2021 Aug 24.
本文引用的文献
1
The ADAMTS13-von Willebrand factor axis in COVID-19 patients.
J Thromb Haemost. 2021 Feb;19(2):513-521. doi: 10.1111/jth.15191. Epub 2020 Dec 18.
2
Dramatic presentation of acquired thombotic thrombocytopenic purpura associated with COVID-19.
Haematologica. 2020 Oct 1;105(10):e540. doi: 10.3324/haematol.2020.262345.
3
Coagulopathy and Thrombosis as a Result of Severe COVID-19 Infection: A Microvascular Focus.
Thromb Haemost. 2020 Dec;120(12):1668-1679. doi: 10.1055/s-0040-1715841. Epub 2020 Aug 24.
4
Covid-19 associated autoimmune thrombotic thrombocytopenic purpura: Report of a case.
Thromb Res. 2020 Nov;195:136-138. doi: 10.1016/j.thromres.2020.07.005. Epub 2020 Jul 5.
5
COVID-19-associated coagulopathy: An exploration of mechanisms.
Vasc Med. 2020 Oct;25(5):471-478. doi: 10.1177/1358863X20932640. Epub 2020 Jun 19.
6
The unique characteristics of COVID-19 coagulopathy.
Crit Care. 2020 Jun 18;24(1):360. doi: 10.1186/s13054-020-03077-0.
7
Autoimmune thrombotic thrombocytopenic purpura (TTP) associated with COVID-19.
Ann Hematol. 2020 Jul;99(7):1673-1674. doi: 10.1007/s00277-020-04097-0. Epub 2020 May 28.
8
COVID-19, microangiopathy, hemostatic activation, and complement.
J Clin Invest. 2020 Aug 3;130(8):3950-3953. doi: 10.1172/JCI140183.
9
Thrombotic thrombocytopenic purpura: pathogenesis, diagnosis and potential novel therapeutics.
J Thromb Haemost. 2017 Oct;15(10):1889-1900. doi: 10.1111/jth.13764. Epub 2017 Jul 27.
10
Inflammation-associated ADAMTS13 deficiency promotes formation of ultra-large von Willebrand factor.
Haematologica. 2008 Jan;93(1):137-40. doi: 10.3324/haematol.11677.
Zotero 插件